RHY — Rhythm Biosciences Balance Sheet
0.000.00%
Last trade - 00:00
- AU$26.16m
- AU$24.94m
- AU$0.23m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.76 | 1.84 | 2.27 | 7.6 | 4.17 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.798 | 0.139 | 0.164 | 0.081 | 0.066 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.61 | 2.01 | 2.49 | 7.77 | 7.12 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.09 | 0.103 | 0.114 | 0.07 | 0.105 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 6.23 | 2.65 | 3.07 | 8.44 | 7.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.373 | 0.794 | 1.34 | 0.932 | 1.77 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.38 | 0.803 | 1.36 | 1.07 | 1.82 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 5.85 | 1.84 | 1.71 | 7.37 | 5.87 |
Total Liabilities & Shareholders' Equity | 6.23 | 2.65 | 3.07 | 8.44 | 7.7 |
Total Common Shares Outstanding |